MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Feasibility of AI-Assisted Screening for Early Parkinson’s in Resource-Limited Settings

F. Zaier, M. Zribi (Tunis, Tunisia)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Artificial Intelligence (AI) and Machine Learning

Objective: To evaluate the feasibility of AI-assisted screening for early Parkinson’s disease (PD) in Tunisian primary care.

Background: PD poses a growing challenge in Tunisia, with an estimated burden of 1.5 years lived with disability (YLD), 5.6 years of life lost (YLL), and 7.1 disability-adjusted life years (DALY) per 100,000 population [1]. However, diagnosis is often delayed due to a shortage of neurologists (2.3 per 100,000). AI tools using voice analysis, motor assessments, and facial recognition have shown promise in early PD detection [2], but their feasibility remains untested.

Method:

A two-phase mixed-methods feasibility study.

Phase 1: Retrospective Analysis of Clinical Pathways

Data: Retrospective patient records (2018–2023) from Tunisian neurology wards.

Outcomes: Time from GP consultation to diagnosis, referral rates, and urban/rural access disparities.

Analysis: Kaplan-Meier for diagnostic delays and logistic regression to identify delay predictors.

Phase 2: Feasibility Assessment of AI-Assisted Screening

AI-Model Selection: Review of validated PD screening models (voice analysis, motor tests) and their applicability to primary care, with performance estimated from literature if local validation is unavailable.

Stakeholder Input: Interviews with GPs and neurologists to assess barriers like internet access, training, and patient acceptability.

Simulation: ABM (NetLogo/Python) to simulate AI screening impact on diagnostic delays, factoring in AI sensitivity, GP adoption, and adherence.

Results: Primary outcome: Estimated reduction in diagnostic delay with AI-assisted screening compared to standard practice, based on retrospective data and simulation projections.

Secondary outcomes: GP adoption feasibility (measured by willingness to integrate AI, training completion rates, and perceived usefulness), patient referral efficiency, and rural vs. urban differences in screening effectiveness.

Sensitivity analyses: The impact of GP training level, AI model accuracy, and varying screening uptake rates on diagnostic performance.

Conclusion: This protocol provides a first step toward AI-integrated PD screening in Tunisian primary care. By assessing feasibility and barriers, it informs future AI-driven interventions in Tunisia and other LMICs.

References: 1. Global Health Estimates: Life expectancy and leading causes of death and disability [Internet]. [cited 2025 Mar 12]. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
2. Bourouhou, A., Jilbab, A., Nacir, C., & Hammouch, A. (2016). “Comparison of classification methods to detect Parkinson’s disease.” 2016 International Conference on Electrical and Information Technologies (ICEIT), 421-424. IEEE.

To cite this abstract in AMA style:

F. Zaier, M. Zribi. Feasibility of AI-Assisted Screening for Early Parkinson’s in Resource-Limited Settings [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/feasibility-of-ai-assisted-screening-for-early-parkinsons-in-resource-limited-settings/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/feasibility-of-ai-assisted-screening-for-early-parkinsons-in-resource-limited-settings/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley